Host: Andrea Sottoriva, The Institute of Cancer Research
Date and time: Tue 07-Nov-2017, 11:00-12:30
Room: Default Location
Tumours evolve. Cancer evolution often leads to complex patterns in the data that are hard to interpret. In this session, we will focus on how to measure evolutionary forces using current high-throughput data. The ability of measuring tumour evolution in individual patients will allow better predictions of the course of the disease and aid clinical decisions.
Moritz Gerstung, EMBL-EBI, UK
Francesca Ciccarelli, King’s College London, UK
Raul Rabadan, Columbia University, New York, USA